Brenntag SE Signs Sole Distribution Agreement with Seqens for Pharma Intermediates in Europe
I'm PortAI, I can summarize articles.
Brenntag SE has signed a sole distribution agreement with Seqens for the distribution of over 30 non-GMP pharmaceutical intermediates in Europe. This partnership aims to optimize Brenntag’s portfolio for API synthesis and improve the availability and coverage of these intermediates in the European market.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments